NAUT

NAUTILUS BIOTECHNOLOGY INC

Healthcare | Small Cap

-$0.13

EPS Forecast

$0.28

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.13

Revenue Forecast:

$0.28

EPS Surprise Forecast:

$0.006

Revenue Surprise Forecast:

-$0

Post-release price volatility - High

Post-release Overnight Move:

±8.3%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

60%

Probability of beating revenue consensus:

46%

Probability of beating both EPS & revs consensus:

33%

Probability of missing both EPS & revs consensus:

27%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-1

Beta (β)

Forward Looking Beta (β):

2.00

Earnings volatility

EPS standard deviation:

$0.06

Revenue standard deviation:

$4

As % of share price:

2.14% HIGH

As % of market cap:

1.11% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.06

Revenue 95th %ile:

$5

EPS 75th %ile:

-$0.11

Revenue 75th %ile:

$1

EPS 25th %ile:

-$0.15

Revenue 25th %ile:

-$1

EPS 5th %ile:

-$0.21

Revenue 5th %ile:

-$4

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

37% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

72% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$180

Bid-ask per Share:

$0.05